Figures & data
#1 = [TS = ((Monoclonal antibody) OR (Monoclonal antibodies))].
#2 = [TS = ((((((((((((((TS = (Arteriosclerosis)) OR TS = (Atheromatous Plaques)) OR TS = (Atheromatous Plaque)) OR TS = (Fibroatheroma)) OR TS = (Fibroatheromas)) OR TS = (Arterial Fatty Streak)) OR TS = (Arterial Fatty Streaks)) OR TS = (Atherosclerotic Plaques)) OR TS = (Atherosclerotic Plaque)) OR TS = (Atheroma)) OR TS = (Atheromas)) OR TS = (Atheromatous Plaques)) OR TS = (Atheromatous Plaque)) OR TS = (Atherosclerosis)) OR TS = (Arteriosclerosis)].
#3 = [TS = ((Monoclonal antibody) OR (Monoclonal antibodies)) AND ((((((((((((((TS = (Arteriosclerosis)) OR TS = (Atheromatous Plaques)) OR TS = (Atheromatous Plaque)) OR TS = (Fibroatheroma)) OR TS = (Fibroatheromas)) OR TS = (Arterial Fatty Streak)) OR TS = (Arterial Fatty Streaks)) OR TS = (Atherosclerotic Plaques)) OR TS = (Atherosclerotic Plaque)) OR TS = (Atheroma)) OR TS = (Atheromas)) OR TS = (Atheromatous Plaques)) OR TS = (Atheromatous Plaque)) OR TS = (Atherosclerosis)) OR TS = (Arteriosclerosis)].
(a) Country collaboration map. The collaboration bonds between countries are represented by red lines, with thicker lines indicating stronger collaboration. (b) Network visualization of country. (c) Overlay visualization of country. (d) Corresponding author’s country. SCP, single country publications. MCP, multiple country publications
(a) Most relevant affiliations in the field of mAbs in AS. The nodes’ size and darkness are proportional to the number of documents produced by the affiliation. (b) Top 10 affiliations’ production over time. (c) Collaboration network among institutions.
Supplemental material
Supplemental Material
Download PDF (408.5 KB)Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.